BERLIN (Reuters) - German healthcare group Fresenius SE ( FREG.DE) said it had decided to pull out of its planned acquisition of Akorn ( AKRX.O) after it found data integrity breaches at the U.S. generic drug maker.
Fresenius pulls out of Akorn takeover over data integrity
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться